Absci Corp SEC filings ABSI
Absci Corp has 360 filings in SEC EDGAR's recent list, going back to Apr 21, 2016. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Other events
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Other events
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 24, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Mar 6, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Other events
|
Jan 14, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement
|
Nov 4, 2025 | Oct 31, 2025 |
| 8-K/A |
Amended current report
Results of operations, Other events
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 25, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 28, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Other events
|
Jan 15, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Other events
|
Sep 4, 2024 | Sep 4, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 28, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Other events
|
Dec 20, 2023 | Dec 20, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 7, 2023 | Dec 5, 2023 |
| 8-K |
Current report
Other events
|
Dec 4, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Other events
|
Sep 5, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 17, 2023 | Aug 16, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 14, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results
|
Jun 16, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 6, 2023 | Jun 2, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 16, 2022 | Dec 15, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 2, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 4, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2022 | Sep 15, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 14, 2022 | Jul 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Mar 22, 2022 | Mar 22, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 21, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 10, 2022 | Jan 7, 2022 |
| 8-K |
Current report
Other events
|
Jan 7, 2022 | Jan 7, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 7, 2021 | Sep 7, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 24, 2021 | Aug 20, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 26, 2021 | Jul 26, 2021 |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- ABSI (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Vancouver, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1672688
- Former names
- AbSci, LLC (until Dec 19, 2019)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- OmniAb, Inc. OABI
- NRC Health NRC
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.